KQbi

KQbi focuses on the development and transformation of recombinant protein drugs, as well as the research, production, and sales of human vaccines. Its core technology originates from Li Xiaokun, an academician of the Chinese Academy of Engineering, a Yangtze River Scholar, and the president of Wenzhou Medical University, along with his team, making it a typical project for the transformation of scientific and technological achievements.